SEC Filings | Carisma Therapeutics Inc.

Filing date	Description	Form	View
May 12, 2023	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	View HTML 0001104659-23-059844.pdf 0001104659-23-059844.rtf 0001104659-23-059844.xls
May 12, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-23-059849.pdf 0001104659-23-059849.rtf 0001104659-23-059849.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 11, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001104659-23-058778.pdf 0001104659-23-058778.rtf 0001104659-23-058778.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 02, 2023	EFFECT	EFFECT	View HTML 9999999995-23-001238.pdf 9999999995-23-001238.rtf 9999999995-23-001238.xls
May 02, 2023	EFFECT	EFFECT	View HTML 9999999995-23-001237.pdf 9999999995-23-001237.rtf 9999999995-23-001237.xls
Apr 28, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001104659-23-052069.pdf 0001104659-23-052069.rtf 0001104659-23-052069.xls
Apr 28, 2023	An annual report to security holders	ARS	View HTML 0001104659-23-052074.pdf 0001104659-23-052074.rtf
Apr 28, 2023	CORRESP	CORRESP	View HTML 0001104659-23-052082.pdf 0001104659-23-052082.rtf 0001104659-23-052082.xls
Apr 28, 2023	CORRESP	CORRESP	View HTML 0001104659-23-052078.pdf 0001104659-23-052078.rtf 0001104659-23-052078.xls
Apr 20, 2023	UPLOAD	UPLOAD	View HTML 0000000000-23-003958.pdf 0000000000-23-003958.rtf

Data provided by Kaleidoscope.